SARTORIUS AG |
Market Closed -
Other stock markets
|
After market 01:23:04 pm | |||
| 293 EUR | +0.45% |
|
292.2 | -0.29% |
| 01:23pm | SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg | ZD |
| Apr. 23 | SARTORIUS VORZUEGE : DZ Bank gives a Sell rating | ZD |
| Sales 2024 * | 3.59B 3.84B | Sales 2025 * | 4.03B 4.31B | Capitalization | 18.06B 19.31B |
|---|---|---|---|---|---|
| Net income 2024 * | 209M 223M | Net income 2025 * | 354M 379M | EV / Sales 2024 * | 6.16 x |
| Net Debt 2024 * | 4.05B 4.33B | Net Debt 2025 * | 3.79B 4.05B | EV / Sales 2025 * | 5.42 x |
| P/E ratio 2024 * |
78.1
x | P/E ratio 2025 * |
52.7
x | Employees | 14,614 |
| Yield 2024 * |
0.29% | Yield 2025 * |
0.39% | Free-Float | 35.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Sartorius AG
More recommendations
More press releases
| 1 day | +0.15% | ||
| 1 week | -11.13% | ||
| Current month | -20.51% | ||
| 1 month | -20.90% | ||
| 3 months | -2.33% | ||
| 6 months | +24.73% | ||
| Current year | -12.06% |
1 week
264.90
305.00
1 month
264.90380.10
Current year
264.90383.70
1 year
215.30383.70
3 years
215.30631.60
5 years
157.30631.60
10 years
19.00631.60
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 59 | 99-04-30 | |
| Chief Tech/Sci/R&D Officer | 59 | 94-12-31 | |
Volker Niebel
COO | Chief Operating Officer | 67 | 00-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
BRD | Director/Board Member | 69 | 19-12-31 |
| Director/Board Member | 75 | 11-11-28 | |
| Director/Board Member | 58 | 17-04-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.95% | 2 M€ | +13.56% | - | |
| 0.78% | 0 M€ | 0.00% | - | |
| 0.75% | 962 M€ | -.--% | - | |
| 0.75% | 79 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 293 | +0.45% | 185 974 |
| 24-04-23 | 291.7 | +6.77% | 334,829 |
| 24-04-22 | 273.2 | +0.59% | 141,506 |
| 24-04-19 | 271.6 | -2.62% | 211,066 |
| 24-04-18 | 278.9 | -15.41% | 661,883 |
Delayed Quote Xetra, April 24, 2024 at 11:40 am EDT
More quotes
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Calendar
2024-05-16
- Capital Markets Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
291.7
EUR
Average target price
336.8
EUR
Spread / Average Target
+15.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.06% | 19.32B | |
| -46.02% | 2.7B | |
| +16.10% | 1.83B | |
| -3.24% | 1.63B | |
| +20.19% | 1.2B | |
| -21.52% | 896M | |
| -8.03% | 726M | |
| -16.15% | 701M | |
| +13.21% | 527M | |
| -.--% | 302M |
- Stock Market
- Equities
- SRT3 Stock
